SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001485003-23-000116
Filing Date
2023-08-10
Accepted
2023-08-10 08:36:21
Documents
63
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q carm-20230630.htm   iXBRL 10-Q 1394504
2 EXHIBIT 31.1 carm-20230630xexx311.htm EX-31.1 10668
3 EXHIBIT 31.2 carm-20230630xexx312.htm EX-31.2 10693
4 EXHIBIT 32.1 carm-20230630xexx321.htm EX-32.1 4978
5 EXHIBIT 32.2 carm-20230630xexx322.htm EX-32.2 5001
  Complete submission text file 0001485003-23-000116.txt   5726514

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT carm-20230630.xsd EX-101.SCH 47174
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT carm-20230630_cal.xml EX-101.CAL 56265
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT carm-20230630_def.xml EX-101.DEF 143648
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT carm-20230630_lab.xml EX-101.LAB 577818
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT carm-20230630_pre.xml EX-101.PRE 336667
57 EXTRACTED XBRL INSTANCE DOCUMENT carm-20230630_htm.xml XML 555187
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 231157356
SIC: 2834 Pharmaceutical Preparations